Project Grant R43AR074859

This $556,160 Project Grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (CFDA 93.846) aims to examine the efficacy of a rehabilitation approach called Rehabilitation with Exercise and Psychological Support (REPS) for patients who have undergone ACL reconstruction surgery. The REPS intervention integrates standard exercise rehabilitation with psychological support, including clinician training, patient education videos, and techniques like...

This federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $520,154 to Arcadia University to conduct research on improving quadriceps muscle function and reducing the risk of post-traumatic osteoarthritis in individuals recovering from anterior cruciate ligament (ACL) reconstruction surgery. The key objectives of the project are to: 1) Determine if non-invasive brain...

The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $1,023,154 Project Grant (R01AG084683) to the University of Colorado-Denver to evaluate the effectiveness and implementation of neuromuscular electrical stimulation (NMES) in improving rehabilitation outcomes for patients who have undergone total knee arthroplasty (TKA). The study aims to compare outcomes between patients receiving contemporary rehabilitation with NMES versus usual...

This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, provides $488,782 to conduct research on the use of neuromuscular electrical stimulation (NMES) to address quadriceps weakness and atrophy following anterior cruciate ligament (ACL) injury and reconstruction. The overarching objective is to establish the mechanistic basis for how NMES can mitigate the...

This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $1,197,166 to Rhode Island Hospital to evaluate a neuromuscular mechanism that may explain differences in functional outcomes between two anterior cruciate ligament (ACL) surgery procedures. The overarching objective is to leverage patients enrolled in the BEAR-MOON clinical trial...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $549,437 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, effective September 1, 2024 through June 30, 2029, aims to develop a novel therapy that leverages the Hedgehog signaling pathway to improve tendon-to-bone...

This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $139,050 in funding to the University of Utah over a five-year period from July 2024 to June 2029. The purpose of this award is to support the research of Dr. Stephan Bodkin, an assistant professor at the University of Utah, in investigating the influence of anterior cruciate...

The Rehabilitation Institute of Chicago, doing business as Shirley Ryan AbilityLab, will conduct the "POWER FORWARD STUDY: A CROSS-SECTOR, MULTISITE CLINICAL TRIAL OF A POWERED KNEE-ANKLE-FOOT ORTHOSIS" project under a $1.679 million project grant from the Department of the Army Medical Command. The grant was awarded on August 1, 2022 and will support project activities through July 31, 2026. The project aims to transform health care for service members and the public through...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) has awarded Collamedix Inc. a $300,000 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to establish the feasibility of their "CollaLink" collagen-based scaffold for augmenting primary repair of anterior cruciate ligament (ACL) mid-substance tears. The project aims to demonstrate that the CollaLink scaffold, when placed around an ACL tear, can provide a...

The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), under the ACL National Institute on Disability, Independent Living, and Rehabilitation Research federal grant program (CFDA 93.433), awarded a $100,000 Project Grant to Results Group, LLC to develop and manage an exoskeletal boot system that improves mobility and symptom management for child and adolescent patients with Charcot-Marie-Tooth (CMT) disease. The grant, awarded on June 1, 2025, supports...